A. Wranke Et Al. , "A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study," International Liver Congress (ILC) , vol.68, Paris, France, 2018
Wranke, A. Et Al. 2018. A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study. International Liver Congress (ILC) , (Paris, France).
Wranke, A., Yurdaydin, C., Heidrich, B., Kalliopi, Z., Yalcin, K., Fehmi, T., ... Akarca, U.(2018). A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study . International Liver Congress (ILC), Paris, France
Wranke, A. Et Al. "A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study," International Liver Congress (ILC), Paris, France, 2018
Wranke, A. Et Al. "A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study." International Liver Congress (ILC) , Paris, France, 2018
Wranke, A. Et Al. (2018) . "A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study." International Liver Congress (ILC) , Paris, France.
@conferencepaper{conferencepaper, author={A. Wranke Et Al. }, title={A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study}, congress name={International Liver Congress (ILC)}, city={Paris}, country={France}, year={2018}}